Field notes The Energy Transition for the Rest of Us

Catalyst N° 014 of 125 29 Jan 2024

Tech solutions for solving the cow burp problem

with Charles Brooke, program manager for enteric methane, Spark Climate Solutions

In this note
  1. 01The question
  2. 02The answer
  3. 03The argument
  4. 04What you need to know first
  5. 05Details worth keeping
  6. 06Claims worth citing
  7. 07Where it’s contested

The question

Can technology actually stop cows from burping methane, and how much of the problem can it realistically reach?

The answer

Partly, and the tools that work best are pointed at the wrong animals. Feed additives give real, repeatable reductions, but they have to be fed often, which confines them to feedlots and intensive dairies, while Brooke estimates that over 80% of enteric emissions come from animals on pasture. Large cuts therefore mean stacking partial answers: better nutrition in smallholder systems, breeding for low-methane animals, additives where they can be delivered, and eventually boluses or vaccines. He thinks zero is possible in principle, but only as a combination, and says the research is early.

03The argument

Start with what the methane is doing there, because it explains why this is hard. Ruminants eat forage whose energy is locked in complex molecules they cannot use directly, so they carry a microbial consortium of anaerobic bacteria, fungi, protozoa and viruses that breaks it into volatile fatty acids and simple sugars they can absorb. That fermentation produces carbon dioxide and hydrogen, and methanogens in the rumen combine the two into methane, most of it burped out and some absorbed into the blood and exhaled. This is the largest anthropogenic source of methane globally. The part that matters for every solution downstream is that removing hydrogen is functional, not incidental: if hydrogen accumulates, the fermentation backs up and stops. Methane is not simply waste you can switch off. Suppress it and the hydrogen still has to go somewhere, which is Brooke’s own explanation for why near-total reduction would need more than one intervention.

Diet drives how much methane an animal makes, and the direction is counterintuitive. Dairy cattle eat a high-fiber forage ration with high dry matter intake, and dry matter intake is the best single predictor of methane output. Beef cattle finished in a feedlot eat more grain, whose simpler sugars pass through the rumen faster and are less methanogenic, so a feedlot animal emits considerably less than a dairy cow. Kann draws the obvious inference, that the usual advice to prefer dairy over beef fails at the cow level; Brooke agrees but restores the system view: the United States runs roughly 90 million beef cattle against about 12 million dairy cows, and dairy animals live five or six years through multiple lactations while beef animals are raised to slaughter much younger. Per animal and per sector are different questions, and the diet comparison answers only the first. The same logic produces the most surprising result in the episode, that intensification lowers emissions. Brooke’s Kenyan example: a grazing cow with low-quality byproduct supplementation gives about 180 liters of milk a year and roughly 55 kilograms of methane; a full production ration nearly doubles the methane to about 90 kilograms while raising milk to as much as 4,600 liters, a twenty-fold increase. One well-fed animal can then displace about 25 on the basal diet, if the demand is there. The metric is intensity, methane per unit of product, not methane per cow. He puts the abatement potential from productivity improvement at around 20% and calls it one of the largest marginal abatement opportunities modeled, with the caveat that it needs markets able to absorb the extra milk.

Then the feed additives, where most of the climate tech attention and money have gone, and where the constraint is delivery, not chemistry. Two classes exist. Alternative hydrogen sinks such as nitrate, lactate and fumarate keep hydrogen away from the methanogens, but efficacy is generally under 10% and there are limits on how much you can feed. Methanogenesis inhibitors attack the enzymes directly: 3-NOP, sold as Bovaer and developed by DSM, delivers a consistent 30% average across diets, while bromoform, found in the red seaweed asparagopsis, reaches up to 90% on a high-grain beef feedlot ration but only 40% to 60% in dairy, and Brooke says the reason for that spread is not always clear. The catch is that 3-NOP metabolizes quickly and has to be fed twice a day, and its molecule is too large for a slow-release bolus. So the additives work where animals come to a trough, meaning intensive dairies and feedlots in high-income countries, which Brooke frames as a beachhead rather than the target. By his projection over 80% of enteric emissions come from pastured animals, and none of the current products reach them.

That is what makes the two pasture-oriented paths matter more than their maturity suggests. Bromoform is a smaller molecule, so it might survive in a bolus, a hard pressed mass of up to 300 grams that sits in the rumen releasing slowly, already a standard way to deliver minerals. Vaccines are the other, attractive because they are cheap, cows already receive many, and they need no daily handling, but difficult because the rumen has no immune system. The approach is to provoke a mucosal antibody response that reaches the rumen via saliva and deactivates its target by binding it, probably needing an initial dose plus a booster. The more interesting variant is vaccinating the mother, since methanogens seed the rumen in the first days and weeks of life, so preventing that seeding might shift an animal’s microbial population toward low methane permanently. Efficacy so far is all over the board, mostly in vitro and early in vivo, and Brooke would count anything above 20% as a real win for pasture. Breeding is the piece he is most enthusiastic about: low- and high-methane phenotypes exist, are heritable and trackable, and are worth 20% to 30% without sacrificing production efficiency. What makes it more than another partial answer is a recent demonstration that low-methane animals respond to inhibitors the same way high-methane animals do, so breeding and additives stack rather than overlap, plausibly reaching 60% to 70% together.

04What you need to know first

Enteric methane
Methane from fermentation inside the rumen, released mostly by belching, as opposed to methane from stored manure, a separate agricultural source.
Emissions intensity
Emissions per unit of product, such as methane per liter of milk, rather than per animal. Several claims here change sign depending on which you use.
Hydrogen sinks versus methanogenesis inhibitors
The two families of feed additive. The first diverts hydrogen so less becomes methane; the second blocks the enzymes that make it. Different mechanisms, different efficacy ceilings.
Bolus
A large compressed pill, up to about 300 grams, placed in the rumen to release its contents slowly. Routine for minerals, and the main candidate route for reaching grazing animals that cannot be dosed daily.

05Details worth keeping

  • Most of the world’s ruminants are not in rich countries or in feedlots. Cattle are concentrated in India, Brazil, China, the US, Argentina and the EU, mostly on smallholdings of one or two acres with three or four animals, where livestock are also draft power, status and savings. Any intervention has to work there to matter, which rules out most of what exists.
  • This is not a new field. Work on capturing the energy lost as methane dates to the 1960s on efficiency grounds, with the climate framing arriving in the early 2000s. Chloroform was an early inhibitor and worked, but was bad for the animal; bromoform has a similar mode of action, is less toxic, and is more abundant in tropical red seaweeds.
  • The market today runs on corporate supply chain commitments, insetting and offsetting against emissions targets, plus regulatory talk but no broad requirement to cut enteric methane. California had an early adoption program that Brooke says died in a budget cut.
  • Regulation is the concrete bottleneck in the US, because a methane reduction claim pushes a product into the new animal drug pathway. Notably, the regulator cares only that a product works, not whether it achieves 20% or 30%. One product has cleared it: Experior, from Elanco, approved for ammonia reduction and called the first environmental claim of its kind on a drug platform.

06Claims worth citing

All figures as stated on 2024-01-29. Efficacy numbers in particular come from a research area the guest describes as early, with long-term studies not yet done.

  • Agriculture is about 40% of global methane emissions and enteric fermentation about 70% of that. Methane accounts for roughly half a degree Celsius of warming, enteric methane a little over 0.1 degrees, about a fifth of methane’s share. Brooke
  • US enteric fermentation plus manure management exceed the methane from US natural gas, petroleum and coal mining systems combined. Brooke
  • Roughly 1.5 billion cattle worldwide, about a fifth in India, with China and the US each a little over 100 million head; by his breakdown 77% cattle and about 15% buffalo, the rest sheep and goats. The US herd is roughly 90 million beef cattle against about 12 million dairy cows. Brooke
  • Over 80% of enteric emissions come from animals on pasture, labeled “my projection” rather than a cited figure. Brooke
  • Animal protein consumption up about 20% by 2050, driving livestock emissions up about 46%. Brooke
  • Redirecting methane energy into meat or milk is worth 2% to 12%. Brooke
  • Productivity improvement could abate about 20%, phrased as abating “20% of the emissions that were expected to increase,” so whether the base is total emissions or the projected increase is ambiguous. Brooke
  • Kenya example: about 180 liters of milk and 55 kilograms of methane a year on a basal grazing diet, versus up to 4,600 liters and about 90 kilograms on a full production ration. Brooke
  • Nitrate and similar hydrogen acceptors: efficacy generally below 10%. Brooke
  • 3-NOP, sold as Bovaer and developed by DSM: about 30% reduction consistently across diets, fed twice daily. Brooke
  • Bromoform from asparagopsis seaweed: up to 90% on a beef feedlot ration, 40% to 60% in dairy, with the variability unexplained, and noting feedlot animals already produce less methane. Brooke
  • Breeding for low-methane phenotypes: 20% to 30% at equal efficiency, roughly 60% to 70% stacked with an additive. Brooke
  • Vaccine efficacy above 20% is the hoped-for figure, from early in vitro and in vivo work. Brooke
  • US new animal drug approval averages upwards of eight years; an amended feed additive petition could take about two. Brooke

07Where it’s contested

  • The central pasture figure is an estimate, not a citation. Brooke prefixes the 80%-plus with “my projection,” and every conclusion about the limits of feed additives rests on it.
  • Kann restates it as a head count. After Brooke gives 80% of emissions from pasture, Kann describes feedlot animals as a very small minority of all cattle. Different denominators; only the first is in the transcript.
  • Long-term efficacy is unknown. Nobody knows whether the rumen adapts to these compounds over six months or a year, or whether they need cycling; the trials are expensive and need large numbers of animals.
  • The productivity co-benefit is modeled, not demonstrated. Showing that reduced methane turns into more milk or meat needs thousands of animals on real farms, beyond most trials, so the economic case still rests on models.
  • Vaccines are the least proven piece. Efficacy is all over the board, the work spans in vitro to early in vivo, and the rumen’s lack of an immune system is an unsolved delivery problem, not an engineering detail. The transcript drops the name of one US company working on this as inaudible.
  • Getting to 100% is a judgment, not a result. Brooke says he thinks it is possible, then qualifies that it takes a combination of interventions and that the liberated hydrogen has to be dealt with, and calls this early days.
  • Public acceptance is a live risk. His cautionary example is recombinant bovine somatotropin, which worked but drew enough distrust that milk cartons still advertise its absence. He blames absent education rather than a safety problem, and warns the same could happen here.

Cite as: “Tech solutions for solving the cow burp problem,” The Energy Transition for the Rest of Us, note on Catalyst with Shayle Kann, January 29, 2024. CC BY 4.0. View the Markdown